Berry Consultants in the News


“REMAP-CAP response to the COVID-19 pandemic”, March 17, 2020

“First-of-its-kind trial in ALS spurs hope for brutal disease”
BioPharma Dive, September 25, 2019

“Sean M. Healy & AMG Center for ALS at Mass General launches first ALS Platform Trial with 5 promising drugs”, September 18, 2019

“Experts Discuss Adaptive Platform Clinical Trials”, September 5, 2019

“FDA’s Woodcock defends accelerated approvals and talks of culture shift in clinical trials”
BioPharma Dive, June 5, 2019

“Channel Medsystems Receives U.S. FDA Approval of the Cerene Cryotherapy Device for the Treatment of Heavy Menstrual Bleeding”
PRNewswire, April 2, 2019

“A Frequentist and Bayesian Walk Into A Trial”
BioCentury News, March 22, 2019

“Bayes for Clinicians Who Need to Know but Don’t Like Math”
JN Learning from JAMA Network, Podcast, December 11, 2018

“Gormley’s Take: Innovative Drug Trial Takes On Cancer Menace”
The Wall Street Journal, November 26, 2018

“Bayer’s Regorafenib is the First Drug to Enter GBM AGILE Adaptive Platform Trial”
Business Wire, November 14, 2018

“Tyme’s SM-88 to be included in Pancreatic Cancer Action Network’s (PanCAN’s) Novel “Precision Promise” Adaptive Phase II/III Pancreatic Cancer Trial Platform”
EIN News, October 10, 2018

“FDA Modernizes Clinical Trial Designs and Approaches for Drug Development, Proposing New Guidance on the use of Adaptive Designs and Master Protocols”
FDA in Brief, September 28, 2018

“The Impact Of The Revolutionary I-SPY2 Trial On Early Stage, High-Risk Breast Cancer Treatment: The Future Of Clinical Trials”
PRNewswire, September 7, 2018

“FDA’s Comprehensive Effort to Advance New Innovations: Initiatives to Modernize for Innovation”
FDA Voice, August 29, 2018

“Global Coalition for Adaptive Research Launches to Speed the Discovery & Development of Cures for Patients with Rare & Deadly Diseases”
Business Wire, April 16, 2018

“Precision Promise Spotlighted at International Conference”
Pancreatic Cancer Action Network News, February 22, 2018

“Guidelines Extend Thrombectomy Window to 24 Hours”
MEDPAGE Today, January 24, 2018

“Berry Consultants Announces Formation of Clinical Trial Strategy Team”
Business Wire, February 6, 2017

“Carnegie Mellon Statistics Department recognizes Scott Berry as part of its 50th Anniversary Celebration”
Carnegie Mellon University News, November 22, 2016

“A New Approach for a Deadly Brain Cancer”
FORTUNE Magazine, November 4, 2016

“Two I-SPY 2 Efficacy Papers Released in The New England Journal of Medicine”
QuantumLeap Healthcare News, July 7, 2016

“Berry Consultants Releases FACTS 5 Clinical Trial Simulator”
Business Wire, May 31, 2016

“The GBM AGILE Story”
Cure Brain Cancer Foundation, November 13, 2015

“Global Alliance Forms to find effective response to deadliest brain tumor”
ASU News, November 12, 2015

“How to take clinical research to the next level”
Fortune, October 26, 2015

“ACS Recommends First Mammogram at 45, Transitioning to Biennial Screening After 55”
The Cancer Letter, October 23, 2015

“How the FDA could change the way it approves drugs”
FiveThirtyEight, September 3, 2015

“Testing Drugs Via Platform Trials”
The Wall Street Journal, August 29, 2015

“An Overview of Top Clinical CROs”
Clinical Leader, August 14, 2015

“Mild hypothermia in deceased organ donors improves organ function in kidney transplant”
EurekAlert Science News, July 29, 2015

“Clinical Matchmaker”
The Scientist, June 1, 2015

“FDA Releases Draft Guidance on Adaptive Designs for Medical Device Clinical Studies”
Food and Drug Administration, May 18, 2015

“21st Century Cures Legislative Phase Now Underway”
The House Energy and Commerce Committee, January 27, 2015

European Prevention of Alzheimer’s dementia research initiative launces in Paris
Alzheimer Europe, January 15, 2015

“The Lowdown on Adaptive Clinical Trials with Don Berry”, sponsored by the National Biomarker Development Alliance (NBDA), July 28, 2014.

“Berry Consultants Sessions at 2014 JSM”,
Berry Consultants News Release, July 22, 2014

“Volunteer Faculty Member Serves On National Board to Improve Clinical Trials”,
University of Central Florida, College of Medicine, April 14, 2014

I-SPY 2 Designer Describes Program’s Many Innovations“,
Oncology Live, April 8, 2014

I-SPY 2 Trial Graduates Neratinib for HER2-Positive Breast Cancer“,
Oncology Live, April 7, 2014

A Look at I-SPY 2:  Novel Trial Design May Expand the Scope of Oncology Drug Development“,
Oncology Live, April 2, 2014

“Dr. Jason Connor appointed to PCORI’s Advisory Panel on Clinical Trials”,
PCORI & Berry Consultants News Release, March 25, 2014

“Berry Consultants Gets the FACTS”,
Clinical Informatics News, February 7, 2014

“Berry Consultants Acquires 100% Interest in Clinical Trial Simulation Software”,
YAHOO! News, February 6, 2014

“Multicompany Trials Adapt to Disciplines Beyond Cancer”,
Nature Medicine, January 7, 2014

“Researchers Aim to Speed Cures to Patients”,
The Wall Street Journal, December 30, 2013

“Foundation for the NIH Announces First Results of I-SPY 2 Breast Cancer Clinical Trial”,
Market Watch, December 26, 2013

“New Drug, Study Method Show Breast Cancer Promise”,
YAHOO! News, December 13, 2013

“European Project Mixes Adaptive Design with Trial-Ready Cohort”,
ALZFORUM, December 11, 2013

“Adaptive Clinical Design Addresses The Uncertainties”,
Life Science Leader, October 9, 2013

“How Math Can Improve Drug Trials and Save Lives”,
Chicago Booth Magazine, Fall 2013

“A First Step Toward HGH Testing — in the Wrong Direction”,, July 24, 2013

“Berry Consultants at JSM2013”,
Berry Consultants News Release, July 22, 2013

“Dissent Over a Device to Help Find Melanoma”,
The New York Times, July 20, 2013

“Do Clinical Trials Work?”,
The New York Times, July 13, 2013

“ASA Honors Scott Berry as New Fellow”,
American Statistical Association, June 5, 2013

“Is Breast Cancer Screening Oversold?”,
Audio Medica, March 29, 2013

“PPD taps into Tessella and Berry software for adaptive trial designs”,
PharmaTimes, November 20, 2012

Why You Should Be Adopting Adaptive Trials“,
eCliniqua, September 20, 2012

The Gold Standard’s Flexible Alloy: Adaptive Designs on the Advance“,
Annals of Emergency Medicine, August Issue, 2012

A Mathematical View of Track and Field World Records“,
Inside Science News, August 2, 2012

Tessella and Berry Consultants launch new FACTS™ engine to cover needs
of Personalized Medicine Clinical Trials“,, June 25, 2012

FDA release draft Guidance for accelerated approval of breast cancer
treatments using I-SPY 2 process
“,, June 5, 2012

Pharma and CRO adopt FACTS clinical trial design software“,
Pharmaceutical Business Review, April 5, 2012

“Pharmaceuticals and CROs tool up for smarter clinical trials”,, April 3, 2012

PPD and Berry Consultants Sign Agreement in Bayesian Statistics“,
Business Wire, May 17, 2011

FDA’s $25 Million Pitch for Improving Drug Regulation“,
Science Magazine, October 7, 2010

FACTS 2 Makes Most Clinical Trials Eligible for Design Simulation,”
Bio-IT World, September 16, 2010